News
LGND ▼ -2.1% - Ligand Pharmaceuticals Incorporated
LGND ▼ -2.1% - Ligand Pharmaceuticals Incorporated
$LGND reported Q3 2026 Adj EPS of $2.67, beating the $2.15 estimate by 24.2%. Revenue of $78.7M beat the $77.2M estimate by 1.9%.
29-OCT-2026 07:11 AM ET
Share this post
More filings for $LGND
LGND ▼ -2.1% - Ligand Pharmaceuticals IncorporatedOct 29, 2026LGND ▲ +1.2% - Ligand Pharmaceuticals IncorporatedOct 27, 2026LGND ▼ -2.2% - Ligand Pharmaceuticals IncorporatedOct 22, 2026LGND ▲ +0.5% - Ligand Pharmaceuticals IncorporatedOct 15, 2026LGND ▼ -0.0% - Ligand Pharmaceuticals IncorporatedSep 24, 2026LGND ▼ -0.0% - Ligand Pharmaceuticals IncorporatedSep 22, 2026
View full $LGND filing history →💬 Comments
Loading comments…
Leave a comment